Registry for idiopathic interstitial pneumonias

The Swiss Lung Registry includes patients from the Swiss IIP registry with idiopathic interstitial pneumonias (IIPs), other interstitial lung diseases (ILDs), and survivors of SARS-Cov-2 infection (COVID-19). This prospective cohort study aims to investigate the natural course of disease, response to specific treatments, and risk factors for the development and progression. We collect potentially related exposures and risk factors, clinical data, patient reported outcomes, pulmonary function, and physical performance test. The ongoing collection of blood samples and storage in our bio bank facilitates the investigation of underlying biological mechanisms.

For more information go to www.pneumologie.insel.ch